Infectious Diseases News and Research

RSS

Researchers develop groundbreaking technique to detect chemoresistance using ultrasound

Researchers at Purdue University have developed a technique to better predict chemotherapy resistance in canines and humans.

13 Feb 2024

Glial fibrillary acidic protein levels pinpoint future dementia risk a decade in advance

Researchers identify GFAP as a potent biomarker for predicting dementia risk over a decade before clinical diagnosis, underscoring its potential for early screening and intervention in asymptomatic individuals.

13 Feb 2024

Promising new CMV vaccine shows stronger immune response

An experimental mRNA vaccine against human cytomegalovirus (CMV), a common virus that can infect babies during pregnancy, elicited some of the most promising immune responses to date of any CMV vaccine candidate, according to a study by Weill Cornell Medicine investigators.

12 Feb 2024

New comprehensive report on pediatric long COVID symptoms published

Up to 5.8 million children and youth in the U.S. have experienced symptoms of COVID-19 that persisted long after initial infection.

12 Feb 2024

Understanding the virological properties of SARS-CoV-2 variant JN.1

Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed a worldwide threat.

9 Feb 2024

LSHTM researchers receive £2m funding to develop novel vaccines, diagnostics and therapeutics

Researchers from the London School of Hygiene & Tropical Medicine (LSHTM) have been awarded £2m funding through the UK Research and Innovation's (UKRI) Technology Missions Fund, to develop novel vaccines, diagnostics and therapeutics.

9 Feb 2024

CARB-X awards $1.8 million to Visby Medical to develop a portable rapid PCR test for gonorrhea

Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) will award up to US$1.8 million to biotechnology company, Visby Medical, to develop a portable rapid polymerase chain reaction (PCR) diagnostic to detect the presence of the pathogen that causes gonorrhea, Neisseria gonorrhoeae (NG), and its susceptibility to ciprofloxacin, a former frontline oral antibiotic that can no longer treat resistant NG.

9 Feb 2024

Vaccines safe for pregnant women with HIV but show reduced immune response

A meta-analysis in eClinicalMedicine finds vaccines are safe for pregnant women living with HIV, showing reduced immunogenicity compared to those without HIV but no increase in adverse events, highlighting the need for their inclusion in vaccine trials.

9 Feb 2024

ANU discovery provides new insight into how the immune system fights malaria

Researchers from The Australian National University (ANU) have discovered a previously unknown ability of a group of immune system cells, known as Atypical B cells (ABCs), to fight infectious diseases such as malaria.

8 Feb 2024

Artificial tears linked to drug-resistant bacteria outbreak, CDC finds

CDC scientists trace a multistate outbreak of highly drug-resistant Pseudomonas aeruginosa to a specific brand of over-the-counter artificial tears, underscoring the need for stricter regulation of medical products.

8 Feb 2024

Experimental mRNA vaccine against CMV elicits promising immune responses

7 Feb 2024

Media stories on parental vaccine hesitancy drive a false narrative, distort reality

Media stories focusing on vaccine hesitancy can distort reality and drive a false narrative that a large percentage of parents are refusing to get their children vaccinated, according to an editorial in the New England Journal of Medicine by two pediatricians from the University of Colorado Anschutz Medical Campus.

6 Feb 2024

Promising influenza drug candidate shows activity against resistant variants

Influenza A viruses with induced resistance to a new candidate antiviral drug were found to be impaired in cell culture and weakened in animals, according to a study by researchers in the Center for Translational Antiviral Research at Georgia State University.

6 Feb 2024

HIV patients have been less vaccinated with the full initial regimen against COVID-19

In December, the journal Vaccines published an analysis of COVID-19 vaccination coverage among people with HIV in Catalonia between December 2020 and July 2022.

5 Feb 2024

Congressman off-base in ad claiming Fauci shipped covid to Montana before the pandemic

A fundraising ad for U.S. Rep. Matt Rosendale (R-Mont.) shows a photo of Anthony Fauci, former director of the National Institute of Allergy and Infectious Diseases, behind bars, swarmed by flying bats.

5 Feb 2024

New study reveals cefoxitin as effective first-line treatment for intraamniotic infections

The effectiveness of Cefoxitin in the treatment of Endometritis and Intraamniotic Infections (IAI).

5 Feb 2024

Phase 3 trial of new malaria vaccine reveals promising results in protecting children

Today, peer-reviewed results from a Phase 3 efficacy trial of the R21/Matrix-M™ malaria vaccine were published in The Lancet. The study was conducted across multiple sites in four African countries with 4,800 children aged 5-36 months.

5 Feb 2024

Long COVID and ME/CFS share isimilarities in immune system dysfunction, study finds

A study led by UMass Chan Medical School viral immunologists Liisa Selin, MD, PhD, and Anna Gil, PhD, discovered similarities in immune system dysfunction as a potential biomarker among people living with long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

1 Feb 2024

IU surgeon-scientist investigates the role of sinus microbiome in chronic rhinosinusitis

An Indiana University School of Medicine surgeon-scientist is leading a multi-institutional grant investigating the role of the sinus microbiome in chronic rhinosinusitis, an inflammatory disease that causes the lining of the sinuses to swell.

1 Feb 2024

Study shows nuanced pregnancy outcomes for pregnant individuals with autoimmune disease

For many aspiring mothers with autoimmune disease, pregnancy can be daunting and full of unknowns. In some cases, those suffering from specific autoimmune conditions have chosen to forego pregnancy altogether due to concerns about their disease treatments and adverse pregnancy outcomes.

1 Feb 2024

Infectious Diseases News and Research

Researchers develop groundbreaking technique to detect chemoresistance using ultrasound

Glial fibrillary acidic protein levels pinpoint future dementia risk a decade in advance

Promising new CMV vaccine shows stronger immune response

New comprehensive report on pediatric long COVID symptoms published

Understanding the virological properties of SARS-CoV-2 variant JN.1

LSHTM researchers receive £2m funding to develop novel vaccines, diagnostics and therapeutics

CARB-X awards $1.8 million to Visby Medical to develop a portable rapid PCR test for gonorrhea

Vaccines safe for pregnant women with HIV but show reduced immune response

ANU discovery provides new insight into how the immune system fights malaria

Artificial tears linked to drug-resistant bacteria outbreak, CDC finds

Experimental mRNA vaccine against CMV elicits promising immune responses

Media stories on parental vaccine hesitancy drive a false narrative, distort reality

Promising influenza drug candidate shows activity against resistant variants

HIV patients have been less vaccinated with the full initial regimen against COVID-19

Congressman off-base in ad claiming Fauci shipped covid to Montana before the pandemic

New study reveals cefoxitin as effective first-line treatment for intraamniotic infections

Phase 3 trial of new malaria vaccine reveals promising results in protecting children

Long COVID and ME/CFS share isimilarities in immune system dysfunction, study finds

IU surgeon-scientist investigates the role of sinus microbiome in chronic rhinosinusitis

Study shows nuanced pregnancy outcomes for pregnant individuals with autoimmune disease

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News